ArticleInterdisciplinary sciences, computational life sciences2026
3D Geometric Equivariant Graph Neural Networks with Contrastive Learning for Protein-Ligand Binding Affinity Prediction.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Protein-Ligand Binding Affinity (PLBA) prediction is a key task in computer aided drug design, underpinning virtual screening, lead optimization, and drug repurposing. Despite recent advances in deep learning, many existing methods fail to fully exploit three-dimensional (3D) geometric information and remain sensitive to conformational variability. To address these limitations, we propose 3D-GEGCL, a framework that integrates 3D geometrically equivariant graph neural networks with self-supervised contrastive learning for robust and accurate PLBA prediction. Protein-ligand complexes are represented as atomic-level 3D geometric graphs and encoded using an E(3)-equivariant network to ensure physical consistency under rotations and translations, while contrastive learning enforces representation consistency across geometrically perturbed views. Comprehensive evaluations conducted on the PDBbind v2019 and CSAR-HiQ benchmarks reveal that 3D-GEGCL achieves superior performance over existing leading methods across a range of assessment criteria. Additional ablation analyses validate the synergistic roles of geometric equivariance and contrastive learning, underscoring the robustness and broad applicability of the introduced framework. Implementation scripts for the various model components are publicly accessible via https://github.com/ligaili01/3D-GEGCL .
Indexed as
Identifiers
42645778What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.